
Vulnerability and generosity shine at Houston Health Museum’s gala
Some galas lean on glitz. This one leaned on vulnerability. The Health Museum’s Annual Health Heroes Gala turned the Hotel ZaZa–Museum District honored those who

Artella Solutions Expands Diagnostic Platform into Sleep Medicine Through Strategic Partnership with PranaQ
HOUSTON & NEW YORK–(BUSINESS WIRE)–Artella Solutions Inc. (“ARTELLA”), a leader in SaaS-driven cardiac monitoring and diagnostic intelligence, today announced a strategic partnership with PranaQ, a digital

Future Cardia and Artella Solutions Announce Strategic Collaboration for Next-Generation Implantable Cardiac Monitoring
Partnership leverages ARTELLA’S Active State Monitoring SaaS platform and Certified Independent Diagnostic Testing Facility (IDTF) with Future Cardia’s Implantable Cardiac Devices. HOUSTON & TAMPA, Fla.–(BUSINESS

Industry Disruptors: These Companies Are Leading the Way
With the influx of technological advancements and evolving customer expectations, some companies are not just a part of their industry; they are completely disrupting it.

The Rebirth of CorMedica: CEO Sepand Moshiri’s Recent Journey and New Board Announcement
CorMedica Group is diving into a new chapter with the announcement of its major restructuring and the introduction of a newly designed and appointed board. With

CorMedica Group Inc. announces Sepand Moshiri as its new CEO and changes to its Board of Directors
CorMedica Group announces its new executive leadership team and restructured board of directors: CorMedica Group is a Houston based holding company involved in the acquisition

Heart Health Warriors: Artella Solutions Inc. Wielding the Sword of Innovation in the Battle Against Cardiac Disease
Heart disease is a killer. It claims a life every 37 seconds; it is the cause of around 700,000 deaths per year. And it continues to be

Sepand Moshiri and Artella Solutions Inc.: Overcoming challenges, reinventing cardiac monitoring, and improving lives
Photo courtesy of Artella Solutions Inc. Opinions expressed by Digital Journal contributors are their own. There are over 365,000 cardiac arrests each year in the US, and

Artella Solutions Partners with Wellysis to Revolutionize Cardiac Monitoring in the US with FDA-Approved S-Patch ExL Device
HOUSTON, TX / ACCESSWIRE / March 19, 2024 / Artella Solutions announces a significant collaboration with Wellysis, a leading digital healthcare spin-off company from Samsung.


The Cardiac Wire Show – Accurate and Efficient Remote Cardiac Patient Monitoring
0:53 – Intro to Jacinta and Artella 2:22 – Artella’s patient monitoring approach 3:00 – Physician’s patient monitoring challenges 3:38 – How Artella helps solve

Q&A: CEO returns to cardiac monitoring tech company with a bold blueprint
In this interview, Artella Solutions Cofounder and CEO Sepand Moshiri discusses business turnaround, corporate restructuring and growth within his homebase city and across several states

Artella Solutions, Inc. Announces Expansion into 6 States with New Leadership Team
Growing innovative mobile cardiac telemetry company generating buzz outside of Texas to meet the diagnostic needs of providers to easily monitor, diagnose and treat patients